
Life Sciences
Accelerating drug development demands more than data.
Polynom designs agentic AI solutions purpose-built for pharma and biotech — so your teams move faster from insight to decision, from molecule to market, with full traceability and regulatory control.

The Pharma Value Chain Is Under Structural Pressure
Multiple data silos, fragmented scientific knowledge, tightening regulatory timelines, and rising R&D costs — with no unified intelligence layer. The result: slow insight cycles, underexploited clinical and real-world evidence, and limited visibility into the signals that drive pipeline and portfolio decisions.
Fragmented Scientific Knowledge
Underexploited Clinical Data
Slow Insight-to-Decision Cycles
Regulatory & Compliance Burden
Beyond Chatbots. Beyond Copilots.
Our approach is a production-grade operational layer — not a proof of concept. Agentic pipelines, sovereign infrastructure, and open-source orchestration give pharma and biotech teams full control: from data ingestion to insight delivery, with no vendor lock-in and no black boxes.
Domain-Specific AI Agents
Production-Grade from Day One
Sovereign by Design
Continuous Scientific Optimisation

Service
Description
Patent & Molecular Intelligence
Agentic analysis of chemical representations, patent corpora, and scientific literature to identify molecule-patent linkages across heterogeneous notations — accelerating prior art search, freedom-to-operate analysis, and competitive intelligence for R&D and IP teams.
Medical Content Copilot
Autonomous transformation of articles, abstracts, clinical evidence, and expert video content into structured, exploitable deliverables — Q&A documents, medical briefs, congress syntheses, and field-ready materials — reducing content production time and improving knowledge diffusion across Medical Affairs.
Clinical & Real-World Evidence Engine
Structured exploration, synthesis, and signal detection across clinical trial data, patient journey records, and real-world evidence — enabling data, medical, and market access teams to surface actionable insights faster and build stronger evidence narratives.
